Natera (NTRA) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Natera Reports Second Quarter 2016 Financial Results
August 4, 2016 4:17 PM EDTSAN CARLOS, Calif., Aug. 4, 2016 /PRNewswire/ --Â Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the second quarter ended June 30, 2016 and provided an update on recent business progress.
Recent Accomplishments & Highlights
Generated total revenues of $52.0 million in the second quarter of 2016 compared to $45.1 million in the second quarter of 2015, an increase of 15% Accessioned greater than 103,000 tests in the second quarter of 2016 compared to approximately 69,000 tests accessioned in the second quarter of 2015, an increase... More